Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB DITOSYLATE Cause Pulmonary oedema? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Pulmonary oedema have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 0.5% of all adverse event reports for LAPATINIB DITOSYLATE.

20
Reports of Pulmonary oedema with LAPATINIB DITOSYLATE
0.5%
of all LAPATINIB DITOSYLATE reports
3
Deaths
5
Hospitalizations

How Dangerous Is Pulmonary oedema From LAPATINIB DITOSYLATE?

Of the 20 reports, 3 (15.0%) resulted in death, 5 (25.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.

Is Pulmonary oedema Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB DITOSYLATE Cause?

Diarrhoea (893) Death (665) Nausea (317) Fatigue (301) Vomiting (259) Rash (249) Drug ineffective (183) Malignant neoplasm progression (183) Off label use (141) Disease progression (137)

What Other Drugs Cause Pulmonary oedema?

ADALIMUMAB (1,196) MACITENTAN (1,019) SACUBITRIL\VALSARTAN (958) DASATINIB (873) TREPROSTINIL (866) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (783) AMLODIPINE (774) LENALIDOMIDE (706) FUROSEMIDE (571) IBRUTINIB (494)

Which LAPATINIB DITOSYLATE Alternatives Have Lower Pulmonary oedema Risk?

LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB DITOSYLATE vs LARONIDASE LAPATINIB DITOSYLATE vs LAROTRECTINIB LAPATINIB DITOSYLATE vs LASILIX LAPATINIB DITOSYLATE vs LASIX

Related Pages

LAPATINIB DITOSYLATE Full Profile All Pulmonary oedema Reports All Drugs Causing Pulmonary oedema LAPATINIB DITOSYLATE Demographics